FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Medical Devices

Dont Criminalize Device Truthful Speech: WLF

Washington Legal Foundations asks the 1st Circuit Court of Appeals to reverse the conviction of two former medical device executives for distributing ...

Human Drugs

Allergans Botox Gets Spasticity Expanded Label

FDA approves an Allergan label expansion for Botox to include eight new muscles for treating upper limb spasticity in adults.

Human Drugs

FDA Approves Clozapine REMS Changes

FDA posts upcoming changes to the clozapine REMS (risk evaluation and mitigation strategy).

Biologics

Patient Engagement and Regenerative Medicine Summary

FDA releases the transcript from a 5/6 CBER virtual workshop on patient engagement and regenerative medicine.

Medical Devices

Volpara Health 510(k) for Updated Breast Assessment

FDA clears a Volpara Health 510(k) for the latest version of its key science algorithm, Volpara Imaging Software (VIS 3.2), a breast density assessmen...

Biologics

Genentech BLA for Faricimab for Eye Disorders

FDA accepts for a priority review a Genentech BLA for faricimab for treating wet, or neovascular, age-related macular degeneration and diabetic macula...

Medical Devices

Many Reports of Medical Device Deaths Misclassified: Study

Researchers say many reporters to the FDA MAUDE medical device database misclassify deaths in other categories.

Biologics

FDA OKs Emergent Resumption of Vaccine Production

FDA says Emergent BioSolutions can resume producing J&J Covid-19 vaccine at its Bayview manufacturing facility.

Human Drugs

FDA Approves Mylan Semglee Biosimilar Insulin Product

FDA approves Mylans Semglee, the first biosimilar and interchangeable insulin product approved in the U.S.

Federal Register

Ceclor Not Withdrawn Due to Safety/Efficacy

Federal Register notice: FDA determines that Eli Lillys Ceclor CD (cefaclor extended-release tablets) 375 mg and 500 mg were not withdrawn from sale f...